newsfilter
← Latest News
PR Newswire·

Kuehn Law Encourages Investors of Kymera Therapeutics, Inc. to Contact Law Firm

  • Kuehn Law, PLLC is investigating whether Kymera Therapeutics, Inc. (NASDAQ: KYMR) officers & directors breached fiduciary duties through potential self-dealing.
  • Shareholders may be entitled to damages & corporate governance reforms.
  • Long-term KYMR stockholders can contact Sophia Anne Silayan at [email protected] or call (833) 672-0814 for a free consultation with no obligation.
  • Kuehn Law covers all case costs & charges no fees to investor clients.
  • Shareholders are urged to contact the firm immediately due to potential time limits on enforcing rights.
  • Participation aims to contribute to financial market integrity & fairness.
  • The press release is identified as attorney advertising with prior results not guaranteeing similar outcomes.